http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021512920-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 |
filingDate | 2019-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2021512920-A |
titleOfInvention | (1S, 3S) -3-amino-4- (difluoromethylidene) cyclopentane-1-carboxylic acid in the treatment of tinnitus, acute sensory deafness, Meniere's disease, Turret syndrome, attention deficit hyperactivity disorder, and addiction And use of (S) -3-amino-4- (difluoromethylenyl) cyclopenta-1-ene-1-carboxylic acid |
abstract | Tinnitus, acute sensory deafness, Meniere's disease, Tourette's syndrome with (1S, 3S) -3-amino-4- (difluoromethylidene) cyclopentane-1-carboxylic acid or a pharmaceutically acceptable salt thereof. , ADHD, or a method of treating addiction. (S) -3-amino-4- (difluoromethylenyl) cyclopenta-1-ene-1-carboxylic acid is used to treat tinnitus, acute sensory deafness, Meniere's disease, Tourette's syndrome, ADHD, or addiction. The method is provided. Also provided are therapeutic compositions that can be used to ameliorate one or more symptoms of tinnitus, acute sensory deafness, Meniere's disease, Tourette's syndrome, ADHD, or addiction. |
priorityDate | 2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.